Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study
Ig. Obrosova et L. Fathallah, Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study, DIABETOLOG, 43(8), 2000, pp. 1048-1055
Aims/hypothesis. Aldose reductase inhibitors (ARIs) prevent biochemical abn
ormalities associated with diabetic complications. We evaluated whether a s
hort-term intervention with an adequate dose of ARI, introduced at the very
early, precataractous stage, reversed diabetes-induced metabolic imbalance
s, down-regulation of ATPases and oxidative stress in the lens.
Methods. The groups included mature control and streptozotocin-diabetic rat
s treated with or without ARI sorbinil (65 mg.kg(-1).day(-1), in the diet,
for 2 weeks after 4 weeks of untreated diabetes). Free cytosolic NAD(+):NAD
H and NADP(+):NADPH ratios were calculated from the lactate dehydrogenase a
nd malic enzyme systems. Concentrations of metabolites and adenine nucleoti
des, Na+/K+-ATPase, H+-ATPase and Ca++-independent Mg++-ATPase activities a
nd variables of oxidative stress were measured in individual lenses.
Results. Sorbinil treatment essentially corrected diabetes-induced sorbitol
and fructose accumulation, myo-inositol depletion, decrease in free cytoso
lic NAD(+):NADH ratio and energy deficiency. Malondialdehyde accumulation,
reduced glutathione depletion and the increase in oxidized glutathione:redu
ced glutathione ratio were partially corrected. Free cytosolic NADP(+):NADP
H ratio and 4-hydroxyalkenal concentrations were similarly increased in dia
betic rats treated with or without ARI. Sorbinil did not counteract diabete
s-induced down-regulation of the three ATPase activities.
Conclusion/interpretation. All biochemical changes assessed in our study ar
e known to be prevented by ARIs. Despite the essential normalization of the
sorbitol pathway activity, only part of them were, however, reversed by th
e ARI treatment introduced at the very early, i.e. precataractous, stage of
diabetes. Therefore, intervention studies can easily underestimate the imp
ortance of aldose reductase in the pathogenesis of diabetic complications a
nd should be interpreted with caution.